A retrospective study of the comparison of maternal outcomes in in-vitro-fertilization pregnancy versus spontaneous conception

Reena Yadav; Kanika Chopra; Aditi Goyal

doi:10.18203/2320-1770.ijrcog20234082

Authors

Reena Yadav Department of Obstetrics and Gynaecology, Lady Hardinge Medical College, New Delhi, India
Kanika Chopra Department of Obstetrics and Gynaecology, Lady Hardinge Medical College, New Delhi, India
Aditi Goyal Department of Obstetrics and Gynaecology, Lady Hardinge Medical College, New Delhi, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20234082

Keywords:

In-vitro fertilization, Maternal near miss, Maternal mortality, Spontaneous pregnancy

Abstract

Background: The adverse maternal outcomes of newer technology of IVF have not been studied so far, especially in India. The aim of the study was to compare maternal near miss and mortality between IVF-conceived and spontaneously conceived pregnancies, at a tertiary-level hospital, in Delhi.

Methods: We conducted a retrospective cohort study from 2018-2020. The demographic, obstetrics, past history, obstetric-related morbidity, mode of delivery, details of maternal near miss and mortality, and their reasons were recorded. Similar data from spontaneous conceptions were compiled. Comparison of maternal characteristics was tested using chi-square test, p<0.05 was considered significant.

Results: Mean age of women in the study group was 33.16±5.58 years and in controls was 26.16±4.28 years. The risk of multiple pregnancy (58.5% versus 2%, p<0.0001), pre-eclampsia (62.8% versus 17.1%, p<0.0001), gestational diabetes mellitus (23.5% versus 14.2%, p=0.0493), intrahepatic cholestasis of pregnancy (32.8% versus 10%, p<0.0001), antepartum haemorrhage (12.1% versus 2.85%, p=0.0066), preterm deliveries (66.4% versus 5.7%, <0.0001), and maternal near miss (12.8% versus 0.7%, OR 20.50, 95% CI-2.6979 to 155.8916, p=0.0035) were much higher in the study group as compared to the control group and was statistically significant. The odds of maternal mortality were 4.0882, 95% CI 0.4512 to 37.0465, p=0.2105 in the study group as compared to the control group.

Conclusions: There is a need to counsel couples wanting to conceive with IVF about not just the procedure and success rates of it, but also the potential for pregnancy complications.

Metrics

Metrics Loading ...

References

Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod. 2007;22(6):1506-12.

Martin AS, Monsour M, Kissin DM, Jamieson DJ, Callaghan WM, Boulet SL. Trends in Severe Maternal Morbidity After Assisted Reproductive Technology in the United States, 2008-2012. Obstet Gynecol. 2016;127(1):59-66.

Cromi A, Marconi N, Casarin J, Cominotti S, Pinelli C, Riccardi M, et al. Maternal intra- and postpartum near-miss following assisted reproductive technology: a retrospective study. BJOG Int J Obstet Gynaecol. 2018;125(12):1569-78.

Pattinson R, Say L, Souza JP, van den Broek N, Rooney C. WHO maternal death and near-miss classifications. Bull World Health Organ. 2009;87(10):734.

Dyer S, Chambers GM, de Mouzon J, Nygren KG, Zegers-Hochschild F, Mansour R et al. International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2008, 2009 and 2010. Hum Reprod Oxf Engl. 2016;31(7):1588-609.

Tan SL, Doyle P, Campbell S, Beral V, Rizk B, Brinsden P et al. Obstetric outcome of in vitro fertilization pregnancies compared with normally conceived pregnancies. Am J Obstet Gynecol. 1992;167(3):778-84.

Bergh T, Ericson A, Hillensjö T, Nygren KG, Wennerholm UB. Deliveries and children born after in-vitro fertilisation in Sweden 1982-95: a retrospective cohort study. The Lancet. 1999;354(9190):1579-85.

Modi D, Jindal M, Pednecar G. Co-relation of IVF pregnancy to maternal health and pregnancy outcome at tertiary health care center, goa medical college. J Pub Health Med Res. 2019;7(2):7-13.

Tan J, Qi YN, Zhang J, Wang W, Zhang GT, Zou K et al. The mediation effect of multiple gestations on the association between in vitro fertilisation and severe maternal morbidities: a retrospective cohort study. BMJ Open. 2019;9(7):e022670.

Kashyap S, Claman P. Polycystic ovary disease and the risk of pregnancy-induced hypertension. J Reprod Med. 2000;45(12):991-4.

Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal Outcomes in Singletons Following In Vitro Fertilization: A Meta-Analysis. Obstet Gynecol. 2004;103(3):551.

WHO. Evaluating the quality of care for severe pregnancy complications: the WHO near-miss approach for maternal health, 2011. Available at: https://www.who.int/publications/i/item/9789241502221. Accessed on 02 November 2023.

Puram RK. Sample registration system. Available at: https://srs.census.gov.in/Srs/Account. Accessed on 12 September, 2023.

Wang ET, Ozimek JA, Greene N, Ramos L, Vyas N, Kilpatrick SJ et al. Impact of fertility treatment on severe maternal morbidity. Fertil Steril. 2016;106(2):423-6.

The Assisted Reproductive Technology (Regulation) Act, 2021 and the Surrogacy (Regulation) Act, 2021 | Indian Council of Medical Research | Government of India. Available at: https://main.icmr.nic.in/content/assisted-reproductive-technology-regulation-act-2021-and-surrogacy-regulation-act-2021-0. Accessed on 02 November 2023.